| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 22 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 22 |
| 2 | TACROLIMUS OINTMENT 0.1% | 22 |
| 3 | PREDNISONE | 21 |
| 4 | MYCOPHENOLATE MOFETIL | 20 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 20 |
| 6 | METHYLPREDNISOLONE | 4 |
| 7 | ADALIMUMAB | 3 |
| 8 | AMPHOTERICIN B | 3 |
| 9 | AZATHIOPRINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMPHOTERICIN B LIPOSOME | 1 | 0.0004 |
| 1 | BELATACEPT | 2 | 0.0004 |
| 2 | AMPHOTERICIN B | 3 | 0.0002 |
| 3 | NITRIC OXIDE | 1 | 0.0002 |
| 4 | TACROLIMUS OINTMENT 0.1% | 22 | 0.0002 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 22 | 0.0002 |
| 6 | ITRACONAZOLE | 2 | 0.0002 |
| 7 | MYCOPHENOLATE MOFETIL | 20 | 0.0001 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 20 | 0.0001 |
| 9 | TACROLIMUS | 22 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 2 | Polyene Antifungal [EPC] | 4 | 0.0001 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 5 | Corticosteroid [EPC] | 27 | 0.0000 |
| 6 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 3 | 0.0000 |
| 8 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 9 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |